实验性脑型疟疾中小鼠血管性血友病因子升高但非晚期致病所必需
研究用伯氏疟原虫ANKA株感染Vwf+/+与Vwf-/-小鼠建立实验性脑型疟疾模型,观察血浆VWF、ADAMTS13、血小板、神经症状及脑内细胞聚集。结果显示感染后血浆VWF显著升高,但VWF缺失不影响总体生存、血小板减少及脑内白细胞与血小板聚集,仅感染后第8.5天Vwf-/-小鼠临床特征略优。
要点
- 伯氏疟原虫ANKA感染后Vwf+/+小鼠血浆VWF水平显著升高。
- Vwf-/-与Vwf+/+小鼠总体生存率无差异,脑内血小板和白细胞聚集未因VWF缺失而改变。
- 感染后第8.5天Vwf-/-小鼠临床脑型疟疾特征略优于Vwf+/+小鼠。
核心结论
- 研究提示血浆VWF浓度升高是实验性脑型疟疾的标志,但VWF对晚期实验性脑型疟疾的致病过程无主要影响。
研究设计与样本
- 研究将Vwf+/+与Vwf-/-小鼠感染伯氏疟原虫ANKA(PbANKA)以诱导实验性脑型疟疾,检测感染后血浆VWF、ADAMTS13、血小板计数、神经症状及脑内血小板与白细胞聚集。
主要发现
- PbANKA感染后Vwf+/+小鼠血浆VWF水平显著升高,而ADAMTS13活性未受影响。
- 晚期实验性脑型疟疾时高分子量VWF多聚体消失,可能源于持续存在的高凝状态。
- 感染早期Vwf-/-小鼠网织红细胞数较Vwf+/+小鼠增加,但两组寄生虫血症水平无显著差异。
- Vwf-/-小鼠总体实验性脑型疟疾临床特征与Vwf+/+小鼠相似,但感染后第8.5天Vwf-/-小鼠临床特征略优于Vwf+/+小鼠。
- Vwf-/-与Vwf+/+小鼠总体生存率无差异,PbANKA诱导的血小板减少及脑内白细胞与血小板聚集未因VWF缺失而改变。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cerebral malaria (CM) is the most severe complication of malaria. Endothelial activation, cytokine release, and vascular obstruction are essential hallmarks of CM. Clinical studies have suggested a link between von Willebrand factor (VWF) and malaria pathology. OBJECTIVES: To investigate the contribution of VWF in the pathogenesis of experimental cerebral malaria (ECM). METHODS: Both Vwf+/+ and Vwf-/- mice were infected with Plasmodium berghei ANKA (PbANKA) to induce ECM. Alterations of plasma VWF and ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13), platelet count, neurological features, and accumulation of platelets and leukocytes in the brain were examined following infection. RESULTS: Plasma VWF levels significantly increased upon PbANKA infection in Vwf+/+ animals. While ADAMTS13 activity was not affected, high molecular weight VWF multimers disappeared at the end-stage ECM, possibly due to an ongoing hypercoagulability. Although the number of reticulocytes, a preferential target for the parasites, was increased in Vwf-/- mice compared to Vwf+/+ mice early after infection, parasitemia levels did not markedly differ between the two groups. Interestingly, Vwf-/- mice manifested overall clinical ECM features similar to those observed in Vwf+/+ animals. At day 8.5 post-infection, however, clinical ECM features in Vwf-/- mice were slightly more beneficial than in Vwf+/+ animals. Despite these minor differences, overall survival was not different between Vwf-/- and Vwf+/+ mice. Similarly, PbANKA-induced thrombocytopenia, leukocyte, and platelet accumulations in the brain were not altered by the absence of VWF. CONCLUSIONS: Our study suggests that increased VWF concentration is a hallmark of ECM. However, VWF does not have a major influence in modulating late-stage ECM pathogenesis.
引用
- Kraisin S, Martinod K, Desender L, et al. von Willebrand factor increases in experimental cerebral malaria but is not essential for late-stage pathogenesis in mice. J Thromb Haemost. 2020. PMID: 32485089. doi:10.1111/jth.14932
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。